AKT1 and atherosclerosis: The potential targets of costunolide in AIH were involved in pathways in cancer (hsa05200), PI3K-AKT signaling pathway (hsa04151), lipid and atherosclerosis (hsa05417), MAPK signaling pathway (hsa04010), proteoglycans in cancer (hsa05205), etc.